Article info
Original research
Ethics of split liver transplantation: should a large liver always be split if medically safe?
- Correspondence to Dr Tae Wan Kim, Carnegie Mellon University, Pittsburgh, PA 15213, USA; twkim{at}andrew.cmu.edu
Citation
Ethics of split liver transplantation: should a large liver always be split if medically safe?
Publication history
- Received March 9, 2021
- Accepted June 13, 2021
- First published July 9, 2021.
Online issue publication
September 28, 2022
Article Versions
- Previous version (9 July 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis
- MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study
- Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis
- PNPLA3 gene predicts clinical recovery after sustained virological response in decompensated hepatitis C cirrhosis
- Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?
- Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease
- Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease
- Selection of patients for liver transplantation and allocation of donated livers in the UK
- MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation
- REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial